TORONTO, May 7, 2015 — Highly priced cancer drugs get rushed approvals despite poor trial methodology and little effect on the longevity of patients, cautions York University Professor Dr. Joel Lexchin in the School of Health Policy and Management. “Patients and their doctors should demand that regulators require pharma companies to provide clear evidence of […]
Keele, Glendon and Markham Campus
Contact
(416) 736-2100
Campus Maps